profit from every €100 of sales.
€0€100
Siemens Healthineers
€43.95+0.34% today
-1.2% since Dec 21, 25
1-year low €33.401-year high €47.05
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2021 to 2024.
0%20% a year
You pay €25.33 for every €1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Siemens Healthineers sold, what it kept, and what it did with the cash.
Sales went from €18.0 billion in 2021 to €22.4 billion in 2024, with €1.94 billion of profit last year.
SalesProfit
Siemens Healthineers handed back 50% of the cash it generated last year.
€1.1B
Free cash flow 2024€2.1B
Bought back its own shares€0
Paid as dividends€1.1B
Cash vs. debt€2.7B vs. €780M
Siemens Healthineers vs. similar companies
Siemens Healthineers grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
| Siemens Healthineers | 25.3× · Fair price | ||
 Abbott Laboratories | 28.8× · Fair price | ||
 Medtronic | 27.4× · Fair price | ||
 Stryker | 36.3× · Expensive | ||
 Edwards Lifesciences | 57.4× · Expensive |
AI analysis
An AI analyst reads Siemens Healthineers's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of EUR | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| 17,997 | 21,714 | 21,680 | 22,363 | |
| 6,952 | 8,137 | 7,709 | 8,468 | |
| 2,568 | 2,924 | 2,133 | 2,809 | |
| 3,526 | 4,261 | 3,781 | 4,222 | |
| 1,727 | 2,038 | 1,509 | 1,942 | |
| – | 1.81 | 1.34 | 1.73 | |
| 38.6% | 37.5% | 35.6% | 37.9% | |
| 14.3% | 13.5% | 9.8% | 12.6% | |
| 9.6% | 9.4% | 7.0% | 8.7% |
Balance sheet
| In millions of EUR | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 42,162 | 49,056 | 46,684 | 46,055 |
| Cash | 1,322 | 1,436 | 2,247 | 2,683 |
| Total debt | – | 694 | 633 | 780 |
| Total liabilities | 25,823 | 29,204 | 28,551 | 27,807 |
| 16,321 | 19,836 | 18,081 | 18,199 | |
| – | 1,128 | 1,124 | 1,123 | |
| 10.7% | 9.9% | 8.3% | 11.1% | |
| 10.6% | 10.3% | 8.3% | 10.7% |
Cash flow
| In millions of EUR | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| 2,933 | 2,504 | 2,119 | 2,826 | |
| 674 | 852 | 838 | 696 | |
| 2,259 | 1,652 | 1,281 | 2,130 | |
| Dividends paid | 856 | 955 | 1,066 | 1,063 |
| 255 | 309 | 421 | 0 | |
| – | – | – | – |
Valuation
- 25.3×
- –
- –
- 2.7×
- 2.2×
- 23.1×
- 11.2×
- 4.3%
- 3.9%
- 2.2%
Profitability
- 37.9%
- 12.6%
- 8.7%
- –
- 11.1%
- 9.8%
- –
- –
- –
- –
Growth
- +7.5%
- –
- –
- –
- −0.1%
Financial health
- -0.5×
- 0.04
- –
- 6.3×
- 1.25
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 26%of 963
Top 44%of 894
Top 46%of 632
Bottom 39%of 908
Top 27%of 991
2.2%of the share price, paid each year
On $1,000 invested$22a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
54.7% of its profit
Room to growStretchedMore than it earns: 49.9%
News
Green Electronics Manufacturing - Global Strategic Business Report 2026: Capitalize on a 24.6% CAGR and $90.8 Billion by 2032, Led by Apple, BYD, Foxconn, Samsung, and SiemensYahoo Finance · Nov 5, 2026Global Intelligent Edge Computing Module Market Report 2026 | NVIDIA, Dell, Siemens, Cisco and Intel Capitalize on Edge AI as Market Hits $12.35 Billion by 2030Yahoo Finance · Nov 2, 2026Artificial Intelligence in Healthcare Market Forecasts Growth from $36.67B (2026) to $194.79B by 2031, Profiling Philips, Microsoft, Siemens Healthineers & NVIDIAYahoo Finance · Oct 2, 2026Siemens Energy taps Goldman Sachs for steam turbine stake sale - BloombergSeeking Alpha · Aug 24, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
54No pass
Benjamin Graham
50No pass
Philip Fisher
48No pass
Peter Lynch
57No pass
Joel Greenblatt
33No pass
Charlie Munger
46No pass
Terry Smith
43No pass
Questions about Siemens Healthineers
Is Siemens Healthineers a good stock to buy?
A solid business at a fair price. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Siemens Healthineers AI analysis
What does Siemens Healthineers do?
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It is in Medical Devices, based in Forchheim, Germany, with 74,000 employees.
Does Siemens Healthineers pay a dividend?
Yes. At today's price the dividend is 2.2% a year, about 55% of its yearly profit. In 2024 it paid out €1.06 billion in dividends.
Is Siemens Healthineers stock halal?
Yes. Siemens Healthineers passes our halal screen: its business is permitted and its debt is 2% of its market value, under the 30% limit. How we check
Who are Siemens Healthineers's competitors?
The largest listed companies in the same industry are Abbott Laboratories, Medtronic, Stryker and Edwards Lifesciences. The peers table on this page compares their profit, growth and price with Siemens Healthineers's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.